141 related articles for article (PubMed ID: 4374338)
21. Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens.
Bagatell CJ; Matsumoto AM; Christensen RB; Rivier JE; Bremner WJ
J Clin Endocrinol Metab; 1993 Aug; 77(2):427-32. PubMed ID: 8345047
[TBL] [Abstract][Full Text] [Related]
22. Spermatogenesis in men treated with injections of medroxyprogesterone acetate combined with testosterone enanthate.
Frick J; Danner C; Kunit G; Joos H; Köhle R
Int J Androl; 1982 Jun; 5(3):246-52. PubMed ID: 7118265
[TBL] [Abstract][Full Text] [Related]
23. Administration of norethandrolone and testosterone as a contraceptive agent for men.
Brenner PF; Bernstein GS; Roy S; Jecht EW; Mishell DR
Contraception; 1975 Feb; 11(2):193-207. PubMed ID: 1112088
[TBL] [Abstract][Full Text] [Related]
24. Oligozoospermia induced by exogenous testosterone is associated with normal functioning residual spermatozoa.
Wang C; Leung A; Superlano L; Steiner B; Swerdloff RS
Fertil Steril; 1997 Jul; 68(1):149-53. PubMed ID: 9207601
[TBL] [Abstract][Full Text] [Related]
25. Low dose of cyproterone acetate and testosterone enanthate for contraception in men.
Meriggiola MC; Bremner WJ; Costantino A; Di Cintio G; Flamigni C
Hum Reprod; 1998 May; 13(5):1225-9. PubMed ID: 9647551
[TBL] [Abstract][Full Text] [Related]
26. Gonadotropin-releasing hormone antagonist plus testosterone: a potential male contraceptive.
Bremner WJ; Bagatell CJ; Steiner RA
J Clin Endocrinol Metab; 1991 Sep; 73(3):465-9. PubMed ID: 1874925
[TBL] [Abstract][Full Text] [Related]
27. The effect of monthly depot medroxyprogesterone acetate and testosterone on human spermatogenesis. I. Uniform dosage levels.
Frick J; Bartsch G; Weiske WH
Contraception; 1977 Jun; 15(6):649-68. PubMed ID: 891192
[TBL] [Abstract][Full Text] [Related]
28. Studies with cyproterone acetate for male contraception.
Roy S; Chatterjee S
J Steroid Biochem; 1979 Jul; 11(1B):675-80. PubMed ID: 491632
[TBL] [Abstract][Full Text] [Related]
29. The potential for an androgen male contraceptive.
Cunningham GR; Silverman VE; Thornby J; Kohler PO
J Clin Endocrinol Metab; 1979 Oct; 49(4):520-6. PubMed ID: 479345
[TBL] [Abstract][Full Text] [Related]
30. Comparison between testosterone oenanthate-induced azoospermia and oligozoospermia in a male contraceptive study. IV. Suppression of endogenous testicular and adrenal androgens.
Anderson RA; Wallace AM; Kicman AT; Wu FC
Hum Reprod; 1997 Aug; 12(8):1657-62. PubMed ID: 9308789
[TBL] [Abstract][Full Text] [Related]
31. Effect of testosterone enanthate on testis size.
Palacios A; McClure RD; Campfield A; Swerdloff RS
J Urol; 1981 Jul; 126(1):46-8. PubMed ID: 6788960
[TBL] [Abstract][Full Text] [Related]
32. Endocrinological and physiological features after steroid treatment of male rats.
Hunt DM; Lau IF; Saksena SK; Chang MC
Arch Androl; 1978 Sep; 1(4):311-20. PubMed ID: 736678
[TBL] [Abstract][Full Text] [Related]
33. Progress in research into new methods of fertility regulation for men.
Prog Hum Reprod Res; 1995; (33):2. PubMed ID: 12289975
[TBL] [Abstract][Full Text] [Related]
34. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
[TBL] [Abstract][Full Text] [Related]
35. Proceedings: Reversible contraceptive action of testosterone in males.
Reddy PR
J Reprod Fertil; 1974 May; 38(1):232. PubMed ID: 4842314
[TBL] [Abstract][Full Text] [Related]
36. Prolactin injection, a new contraceptive method: experimental study.
Shafik A
Contraception; 1994 Aug; 50(2):191-9. PubMed ID: 7956218
[TBL] [Abstract][Full Text] [Related]
37. Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception.
Kamischke A; Venherm S; Plöger D; von Eckardstein S; Nieschlag E
J Clin Endocrinol Metab; 2001 Jan; 86(1):303-9. PubMed ID: 11232016
[TBL] [Abstract][Full Text] [Related]
38. Use of norethisterone and estradiol in mini doses as a contraceptive in the male. Efficacy studies in the adult male bonnet monkey (Macaca radiata).
Shetty G; Krishnamurthy H; Krishnamurthy HN; Ramachandra SG; Moudgal NR
Contraception; 1997 Oct; 56(4):257-65. PubMed ID: 9408708
[TBL] [Abstract][Full Text] [Related]
39. Suppression of spermatogenesis in man induced by Nal-Glu gonadotropin releasing hormone antagonist and testosterone enanthate (TE) is maintained by TE alone.
Swerdloff RS; Bagatell CJ; Wang C; Anawalt BD; Berman N; Steiner B; Bremner WJ
J Clin Endocrinol Metab; 1998 Oct; 83(10):3527-33. PubMed ID: 9768659
[TBL] [Abstract][Full Text] [Related]
40. Combination of 19-nortestosterone-hexyloxyphenylpropionate (Anadur) and depot-medroxyprogesterone-acetate (Clinovir) for male contraception.
Knuth UA; Yeung CH; Nieschlag E
Fertil Steril; 1989 Jun; 51(6):1011-8. PubMed ID: 2524404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
